DSM Firmenich AG (DSFIR)

Currency in EUR
93.70
+0.50(+0.54%)
Closed·
DSFIR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
93.1494.78
52 wk Range
55.2295.00
Key Statistics
Prev. Close
93.2
Open
94.06
Day's Range
93.14-94.78
52 wk Range
55.22-95
Volume
481.89K
Average Vol. (3m)
1.05M
1-Year Change
14.352%
Book Value / Share
72.02
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DSFIR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
89.69
Downside
-4.28%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

DSM Firmenich AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

14 Buy
5 Hold
2 Sell
Ratings:
21 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 89.69
(-4.28% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Citi
Buy106.00+13.13%99.00MaintainAug 05, 2026
Berenberg
Hold95.00+1.39%72.00MaintainAug 03, 2026
JPMorgan
Sell68.00-27.43%60.00MaintainAug 03, 2026
UBS
Buy104.00+10.99%86.00MaintainJul 31, 2026
JPMorgan
Sell60.00-35.97%-MaintainJul 08, 2026

DSM Firmenich AG Earnings Call Summary for Q2/2026

  • DSM-Firmenich posted 6% Q2 organic sales growth and 19.5% EBITDA margin; H1 adjusted EPS rose 14% year-over-year on volume-led gains.
  • Company reaffirmed 2026 guidance, targeting ~20% full-year EBITDA margin and 11-12% operating free cash flow conversion.
  • Announced restructuring plan cutting 1,000 jobs with EUR 100M one-time cost, expected to add 1pp margin improvement by 2027.
  • Shares surged 11% to $92.56 in pre-market, near 52-week high, as investors welcomed margin expansion and steady execution.
  • Management cited FX headwinds of EUR 60M in H1 and gross tariff exposure of EUR 150M, though net impact largely mitigated through pricing.
Last Updated: 07/30/2026, 04:05 AM
Read Full Transcript
DSM Firmenich investor slides for Q2/2026
dsm-firmenich H1 2026 slides
Last Update: Jul 30, 2026
See full investor slides

Earnings

Latest Release
Jul 30, 2026
EPS / Forecast
0.88 / 0.91
Revenue / Forecast
2.39B / 2.32B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.28%
Dividend Yield
2.68%
Industry Median 2.69%
Annualized Payout
2.50
Paid unevenly
5-Years Growth
+0.82%
Growth Streak

DSFIR Income Statement

Compare DSFIR to Peers and Sector

Metrics to compare
DSFIR
Peers
Sector
Relationship
P/E Ratio
71.2x19.4x3.7x
PEG Ratio
−0.230.070.00
Price / Book
1.3x1.6x1.6x
Price / LTM Sales
2.5x1.8x1.3x
Upside (Analyst Target)
−3.1%3.2%37.5%
Fair Value Upside
Unlock2.3%0.4%Unlock

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. DSM-Firmenich AG was founded in 1902 and is based in Kaiseraugst, Switzerland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
82.80M33.52%7.72B
Other Institutional Investors
7.47M3.02%696.06M
Public Companies & Retail Investors
156.74M63.45%14.61B
Total
247.01M100.00%23.02B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Artisan Partners Limited Partnership6.53%16,126,0331,502,946
Artisan Partners Funds, Inc. - Artisan International Value Fund6.53%16,126,0331,502,946

People Also Watch

91.820
SY1G
+0.39%
114.87
SPCX
+6.10%
139.05
LEGD
+1.05%
3,386.00
GIVN
-0.50%
109.25
CAPP
+0.23%

FAQ

What Is the DSM Firmenich (DSFIR) Stock Price Today?

The DSM Firmenich stock price today is 93.70 EUR.

What Stock Exchange Does DSM Firmenich Trade On?

DSM Firmenich is listed and trades on the Amsterdam Stock Exchange.

What Is the Stock Symbol for DSM Firmenich?

The stock symbol for DSM Firmenich is "DSFIR."

Does DSM Firmenich Pay Dividends? What’s The Current Dividend Yield?

The DSM Firmenich dividend yield is 0.92%.

What Is the DSM Firmenich Market Cap?

As of today, DSM Firmenich market cap is 23.02B EUR.

What Is DSM Firmenich's Earnings Per Share (TTM)?

The DSM Firmenich EPS (TTM) is 1.28.

When Is the Next DSM Firmenich Earnings Date?

DSM Firmenich will release its next earnings report on Nov 04, 2026.

From a Technical Analysis Perspective, Is DSFIR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has DSM Firmenich Stock Split?

DSM Firmenich has split 0 times.

How Many Employees Does DSM Firmenich Have?

DSM Firmenich has 20786 employees.

What is the current trading status of DSM Firmenich (DSFIR)?

As of Aug 06, 2026, DSM Firmenich (DSFIR) is trading at a price of 93.70 EUR, with a previous close of 93.20 EUR. The stock has fluctuated within a day range of 93.14 EUR to 94.78 EUR, while its 52-week range spans from 55.22 EUR to 95.00 EUR.

What Is DSM Firmenich (DSFIR) Price Target According to Analysts?

The average 12-month price target for DSM Firmenich is 89.69 EUR, with a high estimate of 106 EUR and a low estimate of 67 EUR. 14 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Buy. The stock has an -4.28% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.